Navigation Links
Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
Date:8/27/2007

work through the recently discovered cellular mechanism known as RNA interference, or RNAi. Quark is able to discover novel therapeutic targets based on its proprietary gene discovery platform, BiFAR(TM). This, combined with its ability to design and successfully deliver synthetic molecules of the new class of RNAi therapeutics known as small-interfering RNA, or siRNA, to specific organs in the body, enables the Company to rapidly develop drug candidates. Quark has two internally discovered and developed lead candidates: RTP801i-14 in Phase 1 clinical trial for the treatment of wet age-related macular degeneration, and AKIi-5 for the prevention of acute renal failure. The Company has out-licensed certain siRNA drug candidates to Pfizer on an exclusive worldwide basis. These drug candidates are designed to inhibit Quark's proprietary target gene RTP801, including RTP801i-14. Quark has, in addition, a product candidate portfolio of RNAi therapeutics based on novel targets and therapeutic concepts discovered using BiFAR(TM) and designed for the treatment of oxidative stress associated diseases of the inner ear, lungs and additional organs of the body.

Quark is headquartered in Fremont, California and operates research and development facilities in Boulder, Colorado and Ness-Ziona, Israel. Additional information is available on the Company website at http://www.quarkpharma.com.

Forward-looking statement

Various statements in this release concerning the Company's future expectations, plans and prospects, including its intention to publicly offer shares of its common stock, constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks related to fluctuations in our sto
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Inc. is pleased to announce that the United ... number 7,599,057 titled "Method and Apparatus for Detection ... company. The patent covers the core technology which ... of this patent supports the underlying strategy as ... commercialization," said Dave Dingott, CEO and President of ...
(Date:12/14/2009)... LLC ("Southridge"), an investment firm that provides financing ... that its affiliated fund has closed a private agreement ... financing to Imaging Diagnostic Systems, Inc. (OTCBB: IMDS). ... of Imaging Diagnostic Systems, Southridge has paved a way ... field of early breast cancer detection," said Stephen Hicks, ...
(Date:12/14/2009)... Dec. 14 Environmental health advocates hope ... about health hazards of bisphenol A (BPA), a ... reproductive harm and other illnesses, in time for ... PhD , staff scientist, Natural Resources Defense ... doctor for medical advice, FDA must rely on ...
Breaking Medicine Technology:Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc. 2Toxic Chemical bisphenol A Still Not Banned By FDA; Schumer, Gillibrand Call for Ban; Govt Official Warns Public 2Dr Michael Barry of MGH is New President of Foundation for Informed Medical Decision Making 55396 1Dr Michael Barry of MGH is New President of Foundation for Informed Medical Decision Making 55396 2Dr Michael Barry of MGH is New President of Foundation for Informed Medical Decision Making 55396 3Dr Michael Barry of MGH is New President of Foundation for Informed Medical Decision Making 55396 4Medical Arts Radiology Chooses Optimum Lightpath to Speed Anytime Anywhere Access to Patient Data and Communications 55393 1Medical Arts Radiology Chooses Optimum Lightpath to Speed Anytime Anywhere Access to Patient Data and Communications 55393 2Medical Arts Radiology Chooses Optimum Lightpath to Speed Anytime Anywhere Access to Patient Data and Communications 55393 3AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 1AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 2AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 3AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 4AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 5AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 6AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 7
... ITALYRANCHO CORDOVA, Calif., Jan. 29 ThermoGenesis Corp. (Nasdaq: ... products and services that process and store adult stem ... now being used in two new regenerative medicine programs.These ... to concentrate stem cells from bone marrow, in an ...
... HONOLULU, Jan. 28 Results of a pre-clinical study ... the,potential to be safe, selective, and efficacious as a ... promise in multiple drug delivery options,including nasal spray, transdermal ... American Academy of Pain Medicine,s 25th Annual Meeting. , ...
Other Medicine Technology:ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives 2ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives 3ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives 4Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment 2Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment 3
(Date:12/14/2009)... rates for meth and smoking, but concerns about ... News) -- Fewer teenagers are using methamphetamine, but ... of prescription drugs remains high, U.S. health officials ... drugs, such as the hallucinogenic salvia leaf and ... treatment of attention-deficit hyperactivity disorder (ADHD), appear to ...
(Date:12/14/2009)... 14 Concetta F. Conkling of Moraga, CA, ... CA, has been elected Chair of the Board of ... -- the nearly 90-year-old organization to which Helen Keller devoted ... New York with offices in San Francisco, ... AFB is dedicated to expanding possibilities for people with ...
(Date:12/14/2009)... Regents will be asked to approve naming the women,s ... and Women,s Hospital complex -- after Ted and Jane ... The University of Michigan Health System has ... Jane Von Voigtlander Foundation, the largest gift ever made ... support the construction of a new women,s hospital. ,, ...
(Date:12/14/2009)... ROCHESTER, Minn. -- A recent study, published in the ... new survival data for the blood disorder myelofibrosis. This ... patients with primary myelofibrosis. , Myelofibrosis is a ... blood cells. The result is extensive scarring in the ... often, an enlarged spleen and liver. , "In ...
(Date:12/14/2009)... liver inflammation in cancer patients, researchers say , , ... herb, milk thistle, appears to reduce liver damage ... Chemo drugs often cause liver inflammation, making it ... until the inflammation subsides. These interruptions in therapy ... , "We found that milk thistle, compared to ...
Breaking Medicine News(10 mins):Health News:Marijuana Use No Longer Dropping Among U.S. Teens 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 4Health News:The American Foundation for the Blind Welcomes New Board Chair, Concetta F. Conkling 2Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 2Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 3Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 4Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 5Health News:Herb May Counter Liver Damage From Chemo 2Health News:Herb May Counter Liver Damage From Chemo 3
... its first case of SARS on its border with hard-hit ... man living in Blagoveshchensk on the Amur river, which forms ... tried to persuade the world his country could contain the ... four-nation tour, that China had introduced strict measures to stop ...
... people over age 85 have Alzheimer’s disease. Now, researchers ... some postmenopausal women to develop dementia, which is a ... from Wake Forest University studied more than 4,500 postmenopausal ... Initiative. The WHI came to an early end last ...
... to the illness have been told to quarantine themselves ... Ontario's chief medical officer of health. Precautions taken ... not control dozens of possible new cases. Health ... largest city back on its list of SARS - ...
... The number of cases of a new form of deadly ... and Canada, The SARS virus was first detected in South ... per reports from the World Health Organization the follwing cases ... up-to-date details as of May 23:// , ,Total number of ...
... reported eight new SARS cases Monday, the smallest number ... daily reports on the spread of the SARS epidemic ... in Beijing and Inner Mongolia, bringing China's death toll ... of confirmed SARS cases now stands at 5,316. ...
... an official SARS cover-up, is trying to stop more ... the deadly flu-like virus has caused to the world's ... which hit retail sales and foreign investment last month, ... June and officials should come clean about it. Severe ...
Other Medicine News:Health News:WHO Says Toronto Going Back on SARS-Affected List 2
... Cutter has application in multiple open or ... resection, and/or creation of anastomoses and can ... buttressing materials such as bovine pericardium., ... a total of eight firings. Different cartridges ...
... in Open Procedures with Compact Endoscopic ... Compact-Flex45 No-Knife Articulating Linear Staplers is ... line for open surgical procedures. It ... blue cartridge, a thick-tissue green cartridge, ...
... ENDO CLIP MultApplier reusable clip applier is designed ... loading unit, each of which contains eight (8) ... shaft of the instrument is approximately 12.8" (32.5 ... and use through an appropriately sized Auto Suture ...
ENDO CLIP II ML, 10 mm Pistol Grip Single Use Clip Applier with Medium - Large Super Interlock Titanium Clips...
Medicine Products: